Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7SX4 | 7SX4 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX4 | 7SX4 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 2/2 | |
| 7SX3 | 7SX3 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SX3 | 7SX3 | Human NALCN-FAM155A-UNC79-UNC80 channelosome with CaM bound, conformation 1/2 | |
| 7SWX | 7SWX | SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation) | |
| 7SWW | 7SWW | SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement) | |
| 7SWD | 7SWD | Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound | |
| 7SU1 | 7SU1 | Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4 | |
| 7SU0 | 7SU0 | Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4 | |
| 7STZ | 7STZ | Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11 | |
| 7STZ | 7STZ | Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11 | |
| 7SSR | 7SSR | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
| 7SSR | 7SSR | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093 | |
| 7SSQ | 7SSQ | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
| 7SSQ | 7SSQ | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231 | |
| 7SRS | 7SRS | 5-HT2B receptor bound to LSD in complex with beta-arrestin1 obtained by cryo-electron microscopy (cryoEM) | |
| 7SQ1 | 7SQ1 | BG505.MD39TS Env trimer in complex with Fab from antibody C05 | |
| 7SPP | 7SPP | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02 | |
| 7SPO | 7SPO | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4 | |
| 7SPA | 7SPA | Chlorella virus Hyaluronan Synthase in the GlcNAc-primed, channel-open state | |
| 7SP9 | 7SP9 | Chlorella virus Hyaluronan Synthase in the GlcNAc-primed channel-closed state | |
| 7SOF | 7SOF | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
| 7SOE | 7SOE | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
| 7SOD | 7SOD | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
| 7SOC | 7SOC | SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement | |
| 7SOB | 7SOB | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
| 7SOA | 7SOA | SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement | |
| 7SO9 | 7SO9 | SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement | |
| 7SN3 | 7SN3 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
| 7SN2 | 7SN2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
| 7SJQ | 7SJQ | Ex silico engineering of cystine-dense peptides yielding a potent bispecific T-cell engager | |
| 7SJ0 | 7SJ0 | Antibody A7V3 bound to N-terminal domain of the spike | |
| 7SI2 | 7SI2 | Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD) | |
| 7SI0 | 7SI0 | IgE-Fc in complex with 813 | |
| 7SHZ | 7SHZ | IgE-Fc in complex with HAE | |
| 7SHY | 7SHY | IgE-Fc in complex with omalizumab scFv | |
| 7SHU | 7SHU | IgE-Fc in complex with omalizumab variant C02 | |
| 7SHT | 7SHT | Structure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variant | |
| 7SGM | 7SGM | Crystal structure of a Fab variant containing a fluorescent noncanonical amino acid with blocked excited state proton transfer and in complex with its antigen, CD40L | |
| 7SGF | 7SGF | Lassa virus glycoprotein construct (Josiah GPC-I53-50A) in complex with LAVA01 antibody | |
| 7SGF | 7SGF | Lassa virus glycoprotein construct (Josiah GPC-I53-50A) in complex with LAVA01 antibody | |
| 7SGD | 7SGD | Lassa virus glycoprotein construct(Josiah GPCysR4) recovered from GPC-I53-50 nanoparticle by localized reconstruction | |
| 7SGD | 7SGD | Lassa virus glycoprotein construct(Josiah GPCysR4) recovered from GPC-I53-50 nanoparticle by localized reconstruction | |
| 7SG4 | 7SG4 | Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047 | |
| 7SG2 | 7SG2 | XPA5 TCR in complex with HLA-DQ2-omega1 | |
| 7SG1 | 7SG1 | XPA5 TCR in complex with HLA-DQ2-alpha1 | |
| 7SG0 | 7SG0 | W316 TCR in complex with HLA-DQ2-omega1 | |
| 7SFW | 7SFW | CryoEM structure of Venezuelan Equine Encephalitis virus (VEEV) TC-83 strain VLP in complex with Fab hVEEV-63 (focus refine of the asymmetric unit) | |
| 7SFV | 7SFV | CryoEM structure of Venezuelan Equine Encephalitis virus (VEEV) TC-83 strain VLP in complex with Fab hVEEV-63 | |
| 7SEM | 7SEM | Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins |
